Table 1.
The literature review of case reports of elderly patients (>65) with primary EBV infectious mononucleosis.
| Age | Gender | Presenting symptoms and signs | AST/ALT (units/L) |
Tbili (mg/dL) |
ALKP/GGT (units/L) |
Atypical lymphocytes | Serology/PCR | Radiographic studies | Liver biopsy results |
Treatment and outcome |
|---|---|---|---|---|---|---|---|---|---|---|
| 68 | M | Malaise and jaundice. | 1553/1396 | Tbili 34 Dbili 25 |
147/50 | Present | Pos anti-VCA IgM and negative anti-EBNA. |
Normal imaging. | No biopsy performed. | Supportive management. Improved during hospitalization [13]. |
|
| ||||||||||
| 66 | F | Malaise, anorexia, and jaundice. | 3090/1490 | Tbili 26.4 Dbili 15.1 |
318/no GGT | Present | Pos monospot test, anti-VCA IgM/IgG, and EBV PCR. |
Abd US chronic liver disease changes. | Hepatitis and cirrhosis. | Prednisolone for AIH. Asymptomatic at 2-month followup [14]. |
|
| ||||||||||
| 70 | F | Fever, pharyngitis, and back pain. | 339/390 | Dbili 0.4 |
524/no GGT |
Present | Pos heterophile antibody and anti-VCA IgM/IgG. | No radiographic studies. | No Biopsy performed. | Supportive treatment [1]. |
|
| ||||||||||
| 72 | F | Sore throat, fever jaundice, splenomegaly, and fever. | 904/1258 | Tbili 21.4 DBili 15.9 |
370/250 | Absent | Pos anti-VCA IgM, EBV PCR, anti-EBEA IgM. Neg anti-VCA IgG. | Normal imaging. | No Biopsy performed. |
Supportive management. Fatigue at 6-month followup [4]. |
|
| ||||||||||
| 67 | F | Sore throat, fever, jaundice, and RUQ pain. | 847/499 | Tbili 11.4 Dbili 8.6 |
1389/198 | Present | Pos monospot test and anti-VCA IgM/IgG. | Normal imaging. | Lymphocytic infiltration in portal tracts. |
Supportive management. Asymptomatic at 3-month followup [4]. |
|
| ||||||||||
| 83 | M | Night sweat and weight loss. | 337/407 | Tbili 10.5 |
512/no GGT | Present | Pos heterophile antibody, anti-VCA IgM/IgG, and EBV PCR. | CT revealed splenomegaly and lymphadenopathy. | No biopsy performed. | Supportive management. Asymptomatic at 1 month [15]. |
|
| ||||||||||
| 72 | M | Loss of appetite and jaundice. | ALT-254 | Tbili 2.9 |
677/817 | Present | Pos anti-VCA IgM/IgG and anti-EBNA IgG. | CT revealed splenomegaly. | No biopsy performed. | Supportive management. Asymptomatic at 4 months [16]. |
|
| ||||||||||
| 76 | F | Falls and dizziness. | Not reported | Tbili 5.7 Dbili 1.5 |
Not reported | Absent | Pos anti-VCA IgM/IgG. Neg anti-EBEA and anti-EBNA. | CT revealed aortic lymphadenopathy. | No biopsy performed. | Supportive management. Asymptomatic at 6 months [17]. |
|
| ||||||||||
| 73 | F | Falls and dizziness. | Not reported | Tbili 1.2 Dbili 0.3 |
Not reported | Absent | Pos anti-VCA IgM/IgG. Neg anti-EBEA and anti-EBNA. | Normal imaging. | No biopsy performed. | Supportive management. Asymptomatic at 6 months [17]. |
Abd US: abdominal ultrasound; AIH: autoimmune hepatitis; ALKP: alkaline phosphatase; ALT: alanine aminotransferase; anti-EBEA: anti-EBV early antigen antibody; anti-EBNA: anti-EBV-associated nuclear antigen antibody; anti-VCA: EBV anti-viral caspid antigen antibody; AST: aspartate aminotransferase; Dbili: direct bilirubin; GGT: gamma glutamyl transpeptidase; HIV: human immunodeficiency virus; IgG: immunoglobulin G; IgM: immunoglobulin M; Neg: negative; PCR: polymerase chain reaction; Pos: positive; Tbili: total bilirubin.